Neurofibromatosis
2020 Neurofibromatosis Research Highlights
- The Pain of Neurofibromatosis
- The NFRP Supports the Future of NF Research with Several New Investigator Awards
- The NFRP Joins Efforts to Promote Open Science in NF Research
- Clinical Trials Address Quality of Life for Persons with Neurofibromatosis (NF1, NF2, and Schwannomatosis) with Resiliency Training Delivered via Live Video
- Study Finds That Bevacizumab Treatment for NF2-Related Vestibular Schwannomas Increases Reported Quality of Life in Adults and Children
Last updated Thursday, May 26, 2022